Literature DB >> 12192065

Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C.

Andrew J Gale1, Xiao Xu, Jean-Luc Pellequer, Elizabeth D Getzoff, John H Griffin.   

Abstract

Procoagulant factor Va (FVa) is inactivated via limited proteolysis at three Arg residues in the A2 domain by the anticoagulant serine protease, activated protein C (APC). Cleavage by APC at Arg306 in FVa causes dissociation of the A2 domain from the heterotrimeric A1:A2:A3 structure and complete loss of procoagulant activity. To help distinguish inactivation mechanisms involving A2 domain dissociation from inactivation mechanisms involving unfavorable changes in factor Xa (FXa) affinity, we used our FVa homology model to engineer recombinant FVa mutants containing an interdomain disulfide bond (Cys609-Cys1691) between the A2 and A3 domains (A2-SS-A3 mutants) in addition to cleavage site mutations, Arg506Gln and Arg679Gln. SDS-PAGE analysis showed that the disulfide bond in A2-SS-A3 mutants prevented dissociation of the A2 domain. In the absence of A2 domain dissociation from the A1:A2:A3 trimer, APC cleavage at Arg306 alone caused a sevenfold decrease in affinity for FXa, whereas APC cleavages at Arg306, Arg506, and Arg679 caused a 70-fold decrease in affinity for FXa and a 10-fold decrease in the k(cat) of the prothrombinase complex for prothrombin without any effect on the apparent K(m) for prothrombin. Therefore, for FVa inactivation by APC, dissociation of the A2 domain may provide only a modest final step, whereas the critical events are the cleavages at Arg506 and Arg306, which effectively inactivate FVa before A2 dissociation can take place. Nonetheless, for FVa Leiden (Gln506-FVa) inactivation by APC, A2 domain dissociation may become mechanistically important, depending on the ambient FXa concentration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192065      PMCID: PMC2373598          DOI: 10.1110/ps.0210002

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  37 in total

1.  Complete cDNA and derived amino acid sequence of human factor V.

Authors:  R J Jenny; D D Pittman; J J Toole; R W Kriz; R A Aldape; R M Hewick; R J Kaufman; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

2.  The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity.

Authors:  C T Esmon
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

3.  The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.

Authors:  M E Nesheim; J B Taswell; K G Mann
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

4.  A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition.

Authors:  M F Hockin; K M Cawthern; M Kalafatis; K G Mann
Journal:  Biochemistry       Date:  1999-05-25       Impact factor: 3.162

5.  Three-dimensional model of coagulation factor Va bound to activated protein C.

Authors:  J L Pellequer; A J Gale; E D Getzoff; J H Griffin
Journal:  Thromb Haemost       Date:  2000-11       Impact factor: 5.249

6.  Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways.

Authors:  L Hoekema; G A Nicolaes; H C Hemker; G Tans; J Rosing
Journal:  Biochemistry       Date:  1997-03-18       Impact factor: 3.162

7.  Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit.

Authors:  P J Fay; P J Haidaris; T M Smudzin
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

8.  Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism.

Authors:  S Krishnaswamy; W R Church; M E Nesheim; K G Mann
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

9.  The role of phospholipids and factor Va in the prothrombinase complex.

Authors:  J Rosing; G Tans; J W Govers-Riemslag; R F Zwaal; H C Hemker
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

10.  Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.

Authors:  B O Villoutreix; B Dahlbäck
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

View more
  17 in total

1.  Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.

Authors:  Thomas J Cramer; John H Griffin; Andrew J Gale
Journal:  Pathophysiol Haemost Thromb       Date:  2010-05-22

2.  Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa.

Authors:  Vikas Bhat; Annette von Drygalski; Andrew J Gale; John H Griffin; Laurent O Mosnier
Journal:  Thromb Haemost       Date:  2015-10-15       Impact factor: 5.249

3.  Venom factor V from the common brown snake escapes hemostatic regulation through procoagulant adaptations.

Authors:  Mettine H A Bos; Michael Boltz; Liam St Pierre; Paul P Masci; John de Jersey; Martin F Lavin; Rodney M Camire
Journal:  Blood       Date:  2009-04-13       Impact factor: 22.113

4.  An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanisms.

Authors:  Annette von Drygalski; Vikas Bhat; Andrew J Gale; Patricia M Averell; Thomas J Cramer; Darlene J Elias; John H Griffin; Laurent O Mosnier
Journal:  Blood Adv       Date:  2020-08-11

5.  DSDBASE: a consortium of native and modelled disulphide bonds in proteins.

Authors:  A Vinayagam; G Pugalenthi; R Rajesh; R Sowdhamini
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

6.  Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant.

Authors:  A von Drygalski; T J Cramer; V Bhat; J H Griffin; A J Gale; L O Mosnier
Journal:  J Thromb Haemost       Date:  2014       Impact factor: 5.824

Review 7.  Progress in the understanding of the protein C anticoagulant pathway.

Authors:  Björn Dahlbäck
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

8.  Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V.

Authors:  Andrew J Gale; Thomas J Cramer; Diana Rozenshteyn; Jason R Cruz
Journal:  J Biol Chem       Date:  2008-04-18       Impact factor: 5.157

9.  The tertiary structure and domain organization of coagulation factor VIII.

Authors:  Betty W Shen; Paul Clint Spiegel; Chong-Hwan Chang; Jae-Wook Huh; Jung-Sik Lee; Jeanman Kim; Young-Ho Kim; Barry L Stoddard
Journal:  Blood       Date:  2007-10-26       Impact factor: 22.113

10.  Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.

Authors:  Subramanian Yegneswaran; Phuong M Nguyen; Andrew J Gale; John H Griffin
Journal:  Thromb Haemost       Date:  2009-01       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.